Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

ATLANTA — More than half of the people who stop using GLP-1 drugs regain at least some of the weight within a year, new real-world data showed. The new findings, from a large national claims database, ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other heart problems.

In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of ...